They did not start the 249D process that privilege was another's.
Most on this forum applauded and wanted the legal actions against shareholders to end. They wanted the company to stop paying the legal fees of directors suing in their personal capacity. Really as hard as you try you cannot blame ERM with what happened last year. A year before shareholders had put forward a 249D. Many HC forum players got a very hard and sharp response where the shareholders funds ( part of which they owned) was being used to cause legal actions against them.
Really the history of 79 CR's speaks for itself each one to date has occurred before the new board - You dont seem to get it you take the decision to invest. The value you have in the company is not what you paid but what it trades for today. Forget the losses - they are real. You are left with what they are worth today - mark to market gets rid of the cost.
Really I will be voting no with you so its really irrelevant to the situation.
To be balanced I am appalled that directors did not release the 4C before the end of the month and think that really we do deserve better in regard to communication. I have not been totally happy thinking that they wanted to give us a comprehensive report. However it is inexcusable not to do the basics right and that is just basic. It would at least tell us if with the plant operating better ( hope not certain) the ongoing cash flow losses are reducing.
- Forums
- ASX - By Stock
- EGO
- Ann: Revised Terms on Corporate Transaction with ERM Power
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EGO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online